Strides, Italian company plan JV for drug formulationsIllustrative image – not actual.

Strides Arcolab has teamed up with Ribbon SRL of Italy for joint manufacture and marketing of cephalosporin anti-infective formulations for the regulated markets.

The JV project envisages the development of a facility for manufacture of Ribbon's entire range of cephalosporin drug master files (DMFs) and have access to beta lactum products. The project is estimated to cost Rs.31 crore with the two partners having equal stake in the venture.

 

← All latest storiesBack to top →